Literature DB >> 1379513

Disposition characteristics of macromolecules in the perfused tissue-isolated tumor preparation.

H Imoto1, Y Sakamura, K Ohkouchi, R Atsumi, Y Takakura, H Sezaki, M Hashida.   

Abstract

Disposition characteristics of model macromolecules with different physicochemical characteristics and macromolecular prodrugs of mitomycin C, namely mitomycin C-dextran conjugates, were studied in tissue-isolated tumor preparations of Walker 256 carcinoma with the use of a single-pass vascular perfusion technique. In constant infusion experiments, all radiolabeled macromolecules accumulated in the tumor tissue, but the degree and pattern of distribution greatly varied, depending on their electric charges. Positively charged macromolecules were markedly accumulated compared with those that were neutral or negatively charged. In addition, their concentrations were significantly higher in viable than in necrotic regions, while neutral and negative compounds were distributed in necrotic rather than in viable regions. Pharmacokinetic analysis of tissue concentration-time courses of positively charged diethylaminoethyl and neutral dextrans showed that their movement occurred by convective fluid flow, and that high tissue accumulation of positively charged macromolecules could be explained by strong binding due to electrostatic interaction. For neutral and anionic macromolecules with negligible affinity to the tissue, it was suggested that the final concentration gradient between the viable and necrotic regions was decided by their tissue fluid content. Thus, the present study revealed the basic disposition characteristics of macromolecules in tumor tissue relative to their physicochemical properties.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379513

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Effect of particle size and charge on the disposition of lipid carriers after intratumoral injection into tissue-isolated tumors.

Authors:  T Nomura; N Koreeda; F Yamashita; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

2.  Pharmacokinetic analysis of drug disposition after intratumoral injection in a tissue-isolated tumor perfusion system.

Authors:  A Saikawa; T Nomura; F Yamashita; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake.

Authors:  K Kawabata; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

4.  Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.

Authors:  Y Tsutsumi; S Tsunoda; H Kamada; T Kihira; S Nakagawa; Y Kaneda; T Kanamori; T Mayumi
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.